• Home
• Topics-in-Focus
• Hemoglobinopathies

Overview of EHA's Hemoglobinopathies Initiatives

The EHA Topics-in-Focus Hemoglobinopathies Program  (focus on Sickle Cell Disease) aims to expand awareness and education about these increasingly common genetic diseases in Europe, among healthcare professionals, patients and the general population. The Program addresses medical and public health issues in the prevention, early diagnosis and management of hemoglobinopathies.

EHA's Hemoglobinopathies Initiatives

Sickle Cell Disease Courses*

• Pathophysiology - cell
• Pathophysiology - vessel
• Pathophysiology - tissue
• Epidemiology & Public Health
• Screening and Diagnosis
• Complications
• Treatment
• Gene Therapy
• Hematology Updates - Sickle Cell Disease

Thalassemia Courses*

• Fundamentals
• Morbidities
• Family Planning and QoL
• Treatment
• Gene Therapy
• Follow the Iron
• Hematology Updates β-thalassemia

Education

• Education - Podcasts*
  • SCD in pregnancy 
  • Interventions in Adolescent SCD
  • Social Stigma and SCD
  • Perspectives in SCD - 1
  • Perspectives in SCD - 2
  • Perspectives in SCD - 3
    
    
• Education - Videocasts*
  • Precision Medicine and hemoglobinopathies
  • New Agents for the Treatment of Thalassemia
  • TIF Guidelines for transfusion-dependent Thalassemia
    
    
• Education - Clinical Cases*
  • β-thalassemia (Myra)

*The EHA Campus is accessible with an EHA membership account.

Research

• Specialized Working Groups
  • Red Cells and Iron
    
    
• Research grants
  • Topics-in-Focus Research Grants
    
    
• EHA Research Roadmap
  • EHA Research Roadmap on Hemoglobinopathies

European Affairs

• Advocacy
  • EHA Position Paper: Access to Affordable Orphan Medicines in Europe
    
    
• Alliances & partnerships
  
  • Thalassaemia International Federation (TIF)
  • European Organisation for Rare Diseases (EURORDIS)
  • ERN EuroBloodNet

Meetings & Events

• EHA-SWG Scientific Meeting on Red Cells and Iron Metabolism Defects
  October 12–14, 2023 - Budapest, Hungary
  
  
• Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT)
  October 25–28, 2023 - London, United Kingdom

Relevant articles

• Lancet Haematology Commission SCD
• Gene Therapy of the Hemoglobinopathies
• EHA Research Roadmap on Hemoglobinopathies and Thalassemia
• Precision Medicine and Sickle Cell Disease
• Research in Sickle Cell Disease: From Bedside to Bench to Bedside